Enoblituzumab (Anti-B7-H3 / CD276)

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

• Supplier: Selleck Chemicals
• Product #: A2626
• Sku #: A2626-1mg